ArticleACS medicinal chemistry letters2025

Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors.

Gregory G Aldred et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.